Valora Therapeutics

Target. Decoy. Engage Immunity.

Valora Therapeutics was founded in 2023, is headquartered in La Jolla, United States, lists 11–50 employees, and has $30.0M in recorded funding across 1 round.

Employees
11–50
Founded
2023
Business Model
B2B
Total Funding
$30.0M
Last Round
$30.0M SeedNov 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 7 investors for this company. The full record is or through the API.

About

Valora Therapeutics is developing next-generation multispecific AbLec antibodies and T-Lec T cell engagers that decoy the glyco-immune checkpoint to create therapeutics for cancer and autoimmune disease. Founded in 2023 on technology invented in Carolyn Bertozzi's Stanford laboratory and exclusively licensed from Stanford, the privately held biotech initiated R&D operations in mid-2024 from its San Diego headquarters. The AbLec platform combines a tumor-targeting arm with a lectin decoy domain to remove glycan-mediated immune suppression, while T-Lec recruits T cells for more potent cancer-cell killing.

Summary

Valora Therapeutics is a Biotech company based in La Jolla, United States, founded in 2023. It lists 11–50 employees. It has raised $30.0M in total across 1 round, most recently a $30.0M Seed round in Nov 2024. Investors include Avalon BioVentures, Bregua Corporation and TigerGene.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundNov 2024
$30.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Valora Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/valora-therapeutics"><img src="https://indexed.vc/api/badge/company/valora-therapeutics" alt="Valora Therapeutics on Indexed.vc" width="260" height="76" /></a>